Diisopropylfluorophosphate impairs the transport of membrane-bound organelles in rat cortical axons

Jie Gao, Sean X. Naughton, Heike Wulff, Vikrant Singh, Wayne D. Beck, Jordi Magrane, Bobby Thomas, Navneet Ammal Kaidery, Caterina M. Hernandez, Alvin V. Terry

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The extensive use of organophosphates (OPs) is an ongoing environmental health concern due to multiple reports of OPrelated neurologic abnormalities. The mechanism of the acute toxicity of OPs has been attributed to inhibition of acetylcholinesterase (AChE), but there is growing evidence that this may not account for all the long-term neurotoxic effects of OPs. In previous experiments (using ex vivo and in vitro model systems) we observed that the insecticide OP chlorpyrifos impaired the movements of vesicles and mitochondria in axons. Here, using a time-lapse imaging technique, we evaluated the OP-nerve agent diisopropylfluorophosphate (DFP) across a wide range of concentrations (subnanomolar to micromolar) for effects on fast axonal transport of membrane-bound organelles (MBOs) that contain the amyloid precursor protein (APP) tagged with the fluorescent marker Dendra2 (APPDendra2). Both 1 and 24 hours of exposure to DFP and a positive control compound, colchicine, resulted in a decrease in the velocity of anterograde and retrograde movements of MBOs and an increase in the number of stationary MBOs. These effects occurred at picomolar (100 pM) to low nanomolar (0.1 nM) concentrations that were not associated with compromised cell viability or cytoskeletal damage. Moreover, the effects of DFP on axonal transport occurred at concentrations that did not inhibit AChE activity, and they were not blocked by cholinergic receptor antagonists. Given the fundamental importance of axonal transport to neuronal function, these observations may explain some of the long-term neurologic deficits that have been observed in humans who have been exposed to OPs.

Original languageEnglish (US)
Pages (from-to)645-655
Number of pages11
JournalJournal of Pharmacology and Experimental Therapeutics
Volume356
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Isoflurophate
Organophosphates
Organelles
Axons
Axonal Transport
Membranes
Acetylcholinesterase
Time-Lapse Imaging
Nervous System Malformations
Chlorpyrifos
Environmental Health
Amyloid beta-Protein Precursor
Colchicine
Cholinergic Antagonists
Insecticides
Neurologic Manifestations
Cell Survival
Mitochondria

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine

Cite this

Diisopropylfluorophosphate impairs the transport of membrane-bound organelles in rat cortical axons. / Gao, Jie; Naughton, Sean X.; Wulff, Heike; Singh, Vikrant; Beck, Wayne D.; Magrane, Jordi; Thomas, Bobby; Kaidery, Navneet Ammal; Hernandez, Caterina M.; Terry, Alvin V.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 356, No. 3, 01.03.2016, p. 645-655.

Research output: Contribution to journalArticle

Gao, J, Naughton, SX, Wulff, H, Singh, V, Beck, WD, Magrane, J, Thomas, B, Kaidery, NA, Hernandez, CM & Terry, AV 2016, 'Diisopropylfluorophosphate impairs the transport of membrane-bound organelles in rat cortical axons', Journal of Pharmacology and Experimental Therapeutics, vol. 356, no. 3, pp. 645-655. https://doi.org/10.1124/jpet.115.230839
Gao, Jie ; Naughton, Sean X. ; Wulff, Heike ; Singh, Vikrant ; Beck, Wayne D. ; Magrane, Jordi ; Thomas, Bobby ; Kaidery, Navneet Ammal ; Hernandez, Caterina M. ; Terry, Alvin V. / Diisopropylfluorophosphate impairs the transport of membrane-bound organelles in rat cortical axons. In: Journal of Pharmacology and Experimental Therapeutics. 2016 ; Vol. 356, No. 3. pp. 645-655.
@article{b93d7c4f1a2749619fb4a3cec637f69c,
title = "Diisopropylfluorophosphate impairs the transport of membrane-bound organelles in rat cortical axons",
abstract = "The extensive use of organophosphates (OPs) is an ongoing environmental health concern due to multiple reports of OPrelated neurologic abnormalities. The mechanism of the acute toxicity of OPs has been attributed to inhibition of acetylcholinesterase (AChE), but there is growing evidence that this may not account for all the long-term neurotoxic effects of OPs. In previous experiments (using ex vivo and in vitro model systems) we observed that the insecticide OP chlorpyrifos impaired the movements of vesicles and mitochondria in axons. Here, using a time-lapse imaging technique, we evaluated the OP-nerve agent diisopropylfluorophosphate (DFP) across a wide range of concentrations (subnanomolar to micromolar) for effects on fast axonal transport of membrane-bound organelles (MBOs) that contain the amyloid precursor protein (APP) tagged with the fluorescent marker Dendra2 (APPDendra2). Both 1 and 24 hours of exposure to DFP and a positive control compound, colchicine, resulted in a decrease in the velocity of anterograde and retrograde movements of MBOs and an increase in the number of stationary MBOs. These effects occurred at picomolar (100 pM) to low nanomolar (0.1 nM) concentrations that were not associated with compromised cell viability or cytoskeletal damage. Moreover, the effects of DFP on axonal transport occurred at concentrations that did not inhibit AChE activity, and they were not blocked by cholinergic receptor antagonists. Given the fundamental importance of axonal transport to neuronal function, these observations may explain some of the long-term neurologic deficits that have been observed in humans who have been exposed to OPs.",
author = "Jie Gao and Naughton, {Sean X.} and Heike Wulff and Vikrant Singh and Beck, {Wayne D.} and Jordi Magrane and Bobby Thomas and Kaidery, {Navneet Ammal} and Hernandez, {Caterina M.} and Terry, {Alvin V.}",
year = "2016",
month = "3",
day = "1",
doi = "10.1124/jpet.115.230839",
language = "English (US)",
volume = "356",
pages = "645--655",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Diisopropylfluorophosphate impairs the transport of membrane-bound organelles in rat cortical axons

AU - Gao, Jie

AU - Naughton, Sean X.

AU - Wulff, Heike

AU - Singh, Vikrant

AU - Beck, Wayne D.

AU - Magrane, Jordi

AU - Thomas, Bobby

AU - Kaidery, Navneet Ammal

AU - Hernandez, Caterina M.

AU - Terry, Alvin V.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - The extensive use of organophosphates (OPs) is an ongoing environmental health concern due to multiple reports of OPrelated neurologic abnormalities. The mechanism of the acute toxicity of OPs has been attributed to inhibition of acetylcholinesterase (AChE), but there is growing evidence that this may not account for all the long-term neurotoxic effects of OPs. In previous experiments (using ex vivo and in vitro model systems) we observed that the insecticide OP chlorpyrifos impaired the movements of vesicles and mitochondria in axons. Here, using a time-lapse imaging technique, we evaluated the OP-nerve agent diisopropylfluorophosphate (DFP) across a wide range of concentrations (subnanomolar to micromolar) for effects on fast axonal transport of membrane-bound organelles (MBOs) that contain the amyloid precursor protein (APP) tagged with the fluorescent marker Dendra2 (APPDendra2). Both 1 and 24 hours of exposure to DFP and a positive control compound, colchicine, resulted in a decrease in the velocity of anterograde and retrograde movements of MBOs and an increase in the number of stationary MBOs. These effects occurred at picomolar (100 pM) to low nanomolar (0.1 nM) concentrations that were not associated with compromised cell viability or cytoskeletal damage. Moreover, the effects of DFP on axonal transport occurred at concentrations that did not inhibit AChE activity, and they were not blocked by cholinergic receptor antagonists. Given the fundamental importance of axonal transport to neuronal function, these observations may explain some of the long-term neurologic deficits that have been observed in humans who have been exposed to OPs.

AB - The extensive use of organophosphates (OPs) is an ongoing environmental health concern due to multiple reports of OPrelated neurologic abnormalities. The mechanism of the acute toxicity of OPs has been attributed to inhibition of acetylcholinesterase (AChE), but there is growing evidence that this may not account for all the long-term neurotoxic effects of OPs. In previous experiments (using ex vivo and in vitro model systems) we observed that the insecticide OP chlorpyrifos impaired the movements of vesicles and mitochondria in axons. Here, using a time-lapse imaging technique, we evaluated the OP-nerve agent diisopropylfluorophosphate (DFP) across a wide range of concentrations (subnanomolar to micromolar) for effects on fast axonal transport of membrane-bound organelles (MBOs) that contain the amyloid precursor protein (APP) tagged with the fluorescent marker Dendra2 (APPDendra2). Both 1 and 24 hours of exposure to DFP and a positive control compound, colchicine, resulted in a decrease in the velocity of anterograde and retrograde movements of MBOs and an increase in the number of stationary MBOs. These effects occurred at picomolar (100 pM) to low nanomolar (0.1 nM) concentrations that were not associated with compromised cell viability or cytoskeletal damage. Moreover, the effects of DFP on axonal transport occurred at concentrations that did not inhibit AChE activity, and they were not blocked by cholinergic receptor antagonists. Given the fundamental importance of axonal transport to neuronal function, these observations may explain some of the long-term neurologic deficits that have been observed in humans who have been exposed to OPs.

UR - http://www.scopus.com/inward/record.url?scp=84958986432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958986432&partnerID=8YFLogxK

U2 - 10.1124/jpet.115.230839

DO - 10.1124/jpet.115.230839

M3 - Article

C2 - 26718240

AN - SCOPUS:84958986432

VL - 356

SP - 645

EP - 655

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -